Long-term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasis
Journal of the European Academy of Dermatology and Venereology | Mar 14, 2018
Risk of developing pressure sore in ALS patients: A nationwide cohort study
Journal of the European Academy of Dermatology and Venereology | Mar 13, 2018
Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials
Journal of the European Academy of Dermatology and Venereology | Mar 12, 2018
Assessing the safety of superficial chemical peels in darker skin: A retrospective study
Journal of the American Academy of Dermatology | Mar 11, 2018
The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex
Journal of the American Academy of Dermatology | Mar 10, 2018
Patient-reported symptoms and signs of moderate-to-severe psoriasis treated with guselkumab or adalimumab: Results from the randomized VOYAGE 1 trial
Journal of the European Academy of Dermatology and Venereology | Mar 10, 2018